09/30/15 - Brain Researcher Monique Breteler appointed to the Royal Netherlands Academy
DZNE neuroepidemiologist honored for her research on dementia. The election recognizes her outstanding academic work and international scientific leadership.
09/17/15 - Cancer drug alleviates learning and memory problems in mice
Researchers in Göttingen have identified a cancer drug as a prototype drug that may be used to treat Alzheimer’s disease. This substance, known as “Vorinostat”, was found to alleviate learning and memory problems in mice.
08/31/15 - Overlooked for 30 years: a new kid on the block
A team led by Christian Haass has identified a novel peptide that plays a role in Alzheimer’s disease: The previously overlooked eta-amyloid interferes with neuronal function and may antogonize beta-amyloid – a finding that has ...
08/27/15 - Mystery of polar bear Knut’s disease finally solved
The polar bear suffered from an autoimmune disease of the brain. This non-infectious illness is called “anti-NMDA receptor encephalitis”, with symptoms in human patients similar to those displayed by Knut. Knut is the first wild ...
08/04/15 - Award for a Pioneer of Alzheimer’s Research
British neuroscientist John Hardy will be awarded this year’s “Hartwig Piepenbrock-DZNE Prize” which is endowed with 60,000 Euro. Piepenbrock and the DZNE herewith honor his seminal contributions to the study of Alzheimer’s ...
07/21/15 - MetLife Foundation Award: Munich-based DZNE researcher receives coveted US prize for medical research
Professor Christian Haass, site speaker at the DZNE in Munich, yesterday has been honored by MetLife Foundation in the USA at the Alzheimer’s Association International Conference in Washington DC. Haass, also director of the ...
07/01/15 - DZNE researcher becomes scientific leader of team developing national expert standard on "Nursing Care for People with Dementia"
The number of people in Germany who require nursing care has been rising steadily for years. Demographic developments indicate that this trend will continue. A parallel increase in the number of dementia patients is also being ...
06/23/15 - Diabetes medication reduces dementia risk
Treating people with type 2 diabetes, also known as "age-related diabetes" with antidiabetics reduces their risk for Alzheimer’s and other types of dementia. The risk is most significantly reduced by the drug pioglitazone. ...
06/03/15 - DZNE Researchers find speedometer in the brain
Researchers in Bonn have identified neural circuits in the brains of mice that are pivotal for movement and navigation in space. These nerve cells that are presumed to exist in a similar form in humans, give the start signal for ...
04/17/15 - Fruit fly studies shed light on adaptability of nerve cells
An international team of researchers at DZNE and Tokyo Tech have revealed in a collaborative study - published today in Neuron, that neurons in the eye change on the molecular level when they are exposed to prolonged light.
04/16/15 - Germany’s one-of-a-kind concept aiming to improve the at home medical care for dementia patients delivers first results
Yesterday, the participating scientists from DZNE, the Institute for Community Medicine at the University of Greifswald’s Medical Faculty and family practitioners discussed the status of the study during a symposium held on the ...
04/13/15 - University of Wisconsin-Madison and DZNE Agree to Collaborate on Alzheimer’s, Dementia Research
Officials of both institutions today agreed to collaborate on research efforts with the potential to improve outcomes for patients with neurodegenerative disease and for individuals at increased risk for developing these ...
03/12/15 - Regeneration in a hostile environment - Cancer drug promotes regeneration of damaged neurons.
DZNE researchers show in Science: Cancer drug epothilone promotes neuronal regeneration and improves motor skills after experimental spinal cord injury.
02/23/15 - Dr. Sabine Helling-Moegen is the new Administrative Director of the German Center for Neurodegenerative Diseases
Together with Professor Pierluigi Nicotera, Chairman of the Executive Board and Scientific Director, Helling-Moegen leads the research institute with more than 800 employees spread across nine sites in Germany. Dr. Helling-Moegen ...
11/26/14 - Brain Researchers Pinpoint Gateway to Human Memory
An international team led by researchers of the University of Magdeburg and the DZNE has successfully determined the location, where memories are generated with a level of precision never achieved before. To this end the ...
11/19/2014 - Alzheimer’s disease: Molecular signals cause brain cells to switch into a hectic state
Through experimental studies scientists of the DZNE at the Bonn and Berlin sites have now gained new insights into how Alzheimer’s interferes with the metabolism of astrocytes.
11/13/14 - Diseases of the Brain: Computer Model of Nerve Cells Provides Insights into Communication Problems
In diseases of the brain, such as Alzheimer’s, the neurons fail to communicate correctly with each other. As researchers of the DZNE now report in the journal “Neuron“, these connectivity problems can be ascribed to alterations ...
10/16/14 - From California to Berlin: international neuroscientist Craig Garner strengthens the collaboration of DZNE and Charité
Prof. Craig Garner, jointly appointed by both institutions, studies dementia, with a particular focus on synapses. His aim is to develop therapies that restore disturbed communication between brain cells.
10/14/14 - Physical exercise in old age can stimulate brain fitness, but effect decreases with advancing age
Physical exercise in old age can improve brain perfusion as well as certain memory skills. This is the finding of Magdeburg neuroscientists who studied women and men aged between 60 and 77.
10/09/14 - DZNE researcher elected into the Leopoldina
Prof. Frank Bradke , head of the "Axon Growth and Regeneration" research group at the DZNE in Bonn, has been elected as a member of the Leopoldina, the German National Academy of Sciences.
09/04/14 - Symbolic corner stone was laid by the DZNE: National Health Research in Bonn
One of the largest and most advanced research buildings in North Rhine-Westphalia is currently being erected in Bonn. It comprises approximately 16,000 square meters of usable area.
07/24/14 - A protein couple controls flow of information into the brain’s memory center
DZNE researchers have determined how two molecules known as ‘CKAMP44’ and ‘TARP Gamma-8’ act upon the transmission of nerve signals into the hippocampus.
07/16/14 - Smart Software Supports Outpatient Services for People with Dementia
Living at home as long as possible is a wish expressed by many people with dementia. To enable this, researchers of the German Center for Neurodegenerative Diseases (DZNE) have developed a computer-based procedure that identifies ...
07/07/14 - Parkinson‘s disease: genetic defect triggers multiple damages in neurons
Researchers find dysfunctions in calcium metabolism and in the cell’s “garbage disposal”. Their study shows a link between alterations in the so-called GBA1 gene and cellular dysfunctions in Parkinson’s for the first time. It is ...
05/09/14 - Five-Year Anniversary of the German Center for Neurodegenerative Diseases: NRW-Science Minister Svenja Schulze and BMBF State Secretary Thomas Rachel open ceremonial act
Today, the German Center for Neurodegenerative Diseases (DZNE) celebrates its five-year anniversary with a gala event. A public Science Day will follow tomorrow morning.